Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
2.370
-0.040 (-1.66%)
At close: Sep 17, 2025, 4:00 PM EDT
2.320
-0.050 (-2.11%)
After-hours: Sep 17, 2025, 7:42 PM EDT
Indaptus Therapeutics Stock Forecast
INDP's stock price has decreased by -94.57% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts that cover Indaptus Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $238, which forecasts a 9,942.19% increase in the stock price over the next year. The lowest target is $140 and the highest is $336.
Price Target: $238 (+9,942.19%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Nov 13, 2024.
Analyst Ratings
The average analyst rating for Indaptus Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $224 → $140 | Strong Buy | Maintains | $224 → $140 | +5,807.17% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $336 | Strong Buy | Reiterates | $336 | +14,077.22% | Oct 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $336 | Strong Buy | Reiterates | $336 | +14,077.22% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $336 | Strong Buy | Reiterates | $336 | +14,077.22% | Apr 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $336 | Strong Buy | Reiterates | $336 | +14,077.22% | Sep 20, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-27.11
from -44.96
EPS Next Year
-14.18
from -27.11
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -27.91 | -14.60 | |
| Avg | -27.11 | -14.18 | |
| Low | -26.05 | -13.62 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.